Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,76 USD | +1,90 % | +10,91 % | -59,61 % |
Resumen de negocios
Número de empleados: 40
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 58 | 05/07/13 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 01/10/15 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Walter Kaufmann
CTO | Chief Tech/Sci/R&D Officer | - | 02/01/19 |
Stephan Toutain
COO | Chief Operating Officer | - | 05/03/18 |
David Goldberger
LAW | General Counsel | - | 06/11 |
Adebayo Laniyonu
PRN | Corporate Officer/Principal | - | 05/05/21 |
Daniel Klamer
PRN | Corporate Officer/Principal | - | 01/09/15 |
Juliana Daley
PRN | Corporate Officer/Principal | 37 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 58 | 05/07/13 | |
Tom Skarpelos
FOU | Founder | 57 | 23/01/04 |
Jiong Ma
CHM | Chairman | 60 | 25/05/21 |
Steffen Thomas
BRD | Director/Board Member | 58 | 15/06/15 |
Peter Donhauser
BRD | Director/Board Member | 58 | 08/02/17 |
Director/Board Member | 51 | 02/03/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 82 112 511 | 79 530 715 ( 96,86 %) | 0 | 96,86 % |
Información de la empresa
Anavex Life Sciences Corp.
630 5th Avenue 20th floor
10111, New York
+844 689 3939
http://www.anavex.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-59,61 % | 303 M | |
-1,65 % | 104 mil M | |
+6,75 % | 97,47 mil M | |
+5,71 % | 22,25 mil M | |
-12,60 % | 21,68 mil M | |
-9,70 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-10,17 % | 16,36 mil M | |
+6,12 % | 14,39 mil M | |
+35,47 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción AVXL
- Empresa Anavex Life Sciences Corp.